Related Experiment Video

Updated: Mar 1, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

Systemic Therapy for Metastatic Colorectal Cancer: From Current Standards to Future Molecular Targeted Approaches

Chloe E Atreya1, Rona Yaeger1, Edward Chu1

  • 1From the Gastrointestinal Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Memorial Sloan Kettering Cancer Center, New York, NY; University of Pittsburgh Cancer Institute, Pittsburgh, PA.

American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|June 1, 2017
PubMed

Insights

Advances in metastatic colorectal cancer (mCRC) treatment include new front-line options and molecular biomarkers. Personalized medicine is enhanced by next-generation sequencing and circulating tumor DNA analysis.

Area of Science:

  • Oncology
  • Genomics
  • Personalized Medicine

Background:

  • Significant progress in metastatic colorectal cancer (mCRC) treatment over the last two decades.
  • Development of diverse front-line therapeutic strategies for mCRC.
  • Emergence of sophisticated molecular technologies for biomarker discovery in colorectal cancer (CRC).

Purpose of the Study:

  • To review the evolution of chemotherapy and targeted therapy for front-line mCRC treatment.
  • To discuss molecular technologies, including next-generation sequencing and whole exome sequencing, for personalized medicine.
  • To examine the application of molecular biomarkers in clinical practice for mCRC.

Main Methods:

  • Review of standard chemotherapy and targeted therapy evolution in mCRC.
  • Analysis of advancements in DNA sequencing technologies (NGS, WES).
  • Exploration of circulating tumor DNA (ctDNA) analysis in peripheral blood.

Main Results:

  • Substantial advances in front-line treatment options for mCRC.
  • Identification of novel prognostic and predictive biomarkers through advanced sequencing.
  • Increasing focus on ctDNA analysis for non-invasive biomarker detection.

Conclusions:

  • Personalized medicine in mCRC is increasingly driven by molecular biomarker discovery.
  • Next-generation sequencing and ctDNA analysis are pivotal for tailoring mCRC treatments.
  • Practical implementation of molecular biomarkers is crucial for optimizing individualized patient care in mCRC.

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.5K
Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer06:19

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer

Published on: July 18, 2017

10.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
56
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K